RHC and its subsidiaries are early-stage companies with limited operating histories upon which to evaluate their business and prospects. They are subject to the risks and uncertainties frequently encountered by early-stage companies in rapidly evolving markets, and they may not successfully address these risks.
The companies have incurred and expect to continue to incur operating losses as they invest in product development and growth. They may never achieve or sustain profitability. There can be no assurance that the companies will generate sufficient revenue to fund operations without additional capital.
The companies expect to require substantial additional financing to execute their business plans. Such financing may not be available when needed, or may be available only on terms that are dilutive or otherwise unfavorable. Failure to raise needed capital could require the companies to delay, reduce, or eliminate operations.
Future issuances of equity or convertible instruments, including upon conversion of SAFEs, will dilute existing holders, potentially substantially.
The subsidiaries are raising capital through Simple Agreements for Future Equity ("SAFEs"). SAFEs are not equity, debt, or any other conventional security, and carry significant risks:
The securities are illiquid. There is no public market for them, none is expected to develop, and they are subject to substantial restrictions on transfer under federal and state securities laws. Investors should be prepared to hold their investment indefinitely and to bear the entire economic risk for an indefinite period.
RHC operates across three distinct verticals — luxury mobility (RSAAIDrive), healthcare workflow software (NurseFlows AI), and spatial computing (Dreamyne AI). Each addresses a different market with different customers, competitors, regulatory regimes, and technical requirements. Pursuing multiple verticals simultaneously may strain capital, management attention, and operational resources, and difficulties in one vertical may adversely affect the others or RHC as a whole.
NurseFlows AI operates in a heavily regulated environment, including the Health Insurance Portability and Accountability Act (HIPAA) and related privacy and security rules, as well as evolving regulation of clinical software. Failure to comply, or changes in law, could result in penalties, loss of customers, or inability to operate.
RSAAIDrive operates in a regulated transportation environment subject to licensing, insurance, and local transportation-network-company requirements. Regulatory changes or non-compliance could materially affect the business.
The companies are subject to securities laws governing their offerings and to data-protection laws governing personal information. Non-compliance could result in rescission rights, penalties, or liability.
The companies operate in rapidly evolving markets, including artificial intelligence, against numerous competitors, many of which have greater financial, technical, and marketing resources, larger customer bases, and longer operating histories. The companies may be unable to compete effectively.
The companies depend on the continued development and performance of their technology, including AI systems and third-party platforms and models. These may fail, contain defects, become obsolete, or be replicated by competitors. Reliance on third-party infrastructure and AI providers exposes the companies to outages, price changes, and changes in terms of service.
The companies' success depends in part on protecting their intellectual property, including a proprietary content-structuring engine. Protective measures may be inadequate, competitors may independently develop similar technology, and the companies may face infringement claims, which could be costly to defend.
The companies collect and process sensitive data, including, for NurseFlows AI, information in healthcare contexts. A security breach, unauthorized access, or data loss could result in legal liability, regulatory penalties, remediation costs, and reputational harm, and could materially impair the business.
The companies depend heavily on their founder and a small team of key personnel. The loss of any key person, or the inability to attract and retain qualified personnel, could materially and adversely affect the business. The companies do not currently maintain key-person insurance. [Counsel to confirm.]
RHC and RSAAID LLC are structured as permanent parallel siblings rather than as a single consolidated entity, and intellectual property may be licensed between RHC's subsidiaries and RSAAID LLC. This structure creates related-party relationships and potential conflicts of interest, including in the pricing and terms of intercompany licenses and services. The structure may also create complexity that affects governance, tax treatment, and the rights of investors. Investors in a subsidiary's SAFE are investing in that subsidiary and not in RHC, RSAAID LLC, or the other subsidiaries. [Counsel to expand on intercompany agreements, transfer pricing, and conflict-of-interest governance.]
Any projections, forecasts, or estimates reflect numerous assumptions that may prove incorrect. Actual results are likely to differ from projections, and those differences may be material and adverse. No assurance can be given that any projected result will be achieved.
General economic conditions, including inflation, interest rates, capital-market volatility, and changes in consumer and enterprise spending, may adversely affect demand for the companies' products and their ability to raise capital on acceptable terms.
There is no assurance that the companies will achieve their objectives or that investors will receive any return. Investors should consult their own legal, tax, and financial advisors and should invest only amounts they can afford to lose entirely.